| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidase activity | TPP2 CAPN1 XPNPEP1 PRSS23 ST14 MYSM1 ADGRG6 CFLAR USP2 HPR PAPPA ADAM2 CTSL ENPEP | 9.34e-06 | 654 | 106 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | TPP2 CAPN1 PRSS23 ST14 ADGRG6 CFLAR USP2 HPR PAPPA ADAM2 CTSL | 1.80e-05 | 430 | 106 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.83e-05 | 103 | 106 | 6 | GO:0004725 | |
| GeneOntologyMolecularFunction | cyclin binding | 3.46e-05 | 35 | 106 | 4 | GO:0030332 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 7.74e-05 | 16 | 106 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 7.89e-05 | 43 | 106 | 4 | GO:0004177 | |
| GeneOntologyMolecularFunction | phosphatase activity | 1.47e-04 | 287 | 106 | 8 | GO:0016791 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 2.16e-04 | 386 | 106 | 9 | GO:0042578 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERCC4 POLD1 PON3 PTPN22 PIKFYVE DNASE2B MTMR6 MTMR7 PTPRD PTPRF PTPRS INTS11 ALPI | 3.46e-04 | 807 | 106 | 13 | GO:0016788 |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 3.88e-04 | 27 | 106 | 3 | GO:0034593 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 4.13e-04 | 6 | 106 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 5.17e-04 | 189 | 106 | 6 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 5.32e-04 | 30 | 106 | 3 | GO:0052866 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 5.32e-04 | 30 | 106 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 5.32e-04 | 30 | 106 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 7.09e-04 | 363 | 106 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.14e-03 | 86 | 106 | 4 | GO:0004197 | |
| GeneOntologyMolecularFunction | protein kinase activity | CAMKK1 RIPK1 CDK15 MAP4K3 NRP2 PIKFYVE GUCY2C CDK13 MAP4K5 CDK3 | 1.34e-03 | 600 | 106 | 10 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 1.49e-03 | 11 | 106 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 2.44e-03 | 14 | 106 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | kinase activity | CAMKK1 RIPK1 CDK15 MAP4K3 NRP2 PIKFYVE PALS1 GUCY2C CDK13 MAP4K5 CDK3 | 2.45e-03 | 764 | 106 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.52e-03 | 51 | 106 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.60e-03 | 446 | 106 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.80e-03 | 15 | 106 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 2.81e-03 | 110 | 106 | 4 | GO:0008238 | |
| Domain | PTPc_motif | 9.67e-07 | 59 | 105 | 6 | SM00404 | |
| Domain | Tyr_Pase_cat | 9.67e-07 | 59 | 105 | 6 | IPR003595 | |
| Domain | Tyr_Pase_AS | 3.43e-06 | 73 | 105 | 6 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 8.93e-06 | 86 | 105 | 6 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 9.55e-06 | 87 | 105 | 6 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 9.55e-06 | 87 | 105 | 6 | PS50056 | |
| Domain | - | 1.32e-05 | 92 | 105 | 6 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.01e-05 | 99 | 105 | 6 | IPR029021 | |
| Domain | SLIDE | 3.13e-05 | 2 | 105 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 3.13e-05 | 2 | 105 | 2 | IPR015194 | |
| Domain | SLIDE | 3.13e-05 | 2 | 105 | 2 | PF09111 | |
| Domain | HAND | 3.13e-05 | 2 | 105 | 2 | PF09110 | |
| Domain | ISWI | 3.13e-05 | 2 | 105 | 2 | IPR029915 | |
| Domain | PTPc | 4.84e-05 | 36 | 105 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.67e-05 | 39 | 105 | 4 | PS50055 | |
| Domain | PTPase_domain | 8.14e-05 | 41 | 105 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 8.14e-05 | 41 | 105 | 4 | PF00102 | |
| Domain | DBINO | 9.36e-05 | 3 | 105 | 2 | IPR020838 | |
| Domain | DBINO | 9.36e-05 | 3 | 105 | 2 | PF13892 | |
| Domain | CUB | 1.64e-04 | 49 | 105 | 4 | PF00431 | |
| Domain | SANT | 1.78e-04 | 50 | 105 | 4 | SM00717 | |
| Domain | CUB | 1.78e-04 | 50 | 105 | 4 | SM00042 | |
| Domain | MAPKKKK | 1.86e-04 | 4 | 105 | 2 | IPR021160 | |
| Domain | - | 2.07e-04 | 52 | 105 | 4 | 2.60.120.290 | |
| Domain | SANT/Myb | 2.07e-04 | 52 | 105 | 4 | IPR001005 | |
| Domain | CUB | 2.23e-04 | 53 | 105 | 4 | PS01180 | |
| Domain | CUB_dom | 2.96e-04 | 57 | 105 | 4 | IPR000859 | |
| Domain | SANT_dom | 4.09e-04 | 26 | 105 | 3 | IPR017884 | |
| Domain | PbH1 | 4.63e-04 | 6 | 105 | 2 | SM00710 | |
| Domain | HELP | 4.63e-04 | 6 | 105 | 2 | PF03451 | |
| Domain | HELP | 4.63e-04 | 6 | 105 | 2 | IPR005108 | |
| Domain | PbH1 | 4.63e-04 | 6 | 105 | 2 | IPR006626 | |
| Domain | SANT | 5.11e-04 | 28 | 105 | 3 | PS51293 | |
| Domain | Pectin_lyase_fold/virulence | 8.57e-04 | 8 | 105 | 2 | IPR011050 | |
| Domain | Myb_DNA-binding | 9.91e-04 | 35 | 105 | 3 | PF00249 | |
| Domain | RuvA_2-like | 1.10e-03 | 9 | 105 | 2 | IPR010994 | |
| Domain | MYB_LIKE | 1.26e-03 | 38 | 105 | 3 | PS50090 | |
| Domain | Pkinase | 1.39e-03 | 381 | 105 | 8 | PF00069 | |
| Domain | fn3 | 2.22e-03 | 162 | 105 | 5 | PF00041 | |
| Domain | Myotubularin-like_Pase_dom | 2.73e-03 | 14 | 105 | 2 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.73e-03 | 14 | 105 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 2.73e-03 | 14 | 105 | 2 | IPR030564 | |
| Domain | Myotub-related | 2.73e-03 | 14 | 105 | 2 | PF06602 | |
| Domain | CNH | 2.73e-03 | 14 | 105 | 2 | SM00036 | |
| Domain | CNH | 3.13e-03 | 15 | 105 | 2 | PF00780 | |
| Domain | CNH | 3.13e-03 | 15 | 105 | 2 | PS50219 | |
| Domain | CNH_dom | 3.13e-03 | 15 | 105 | 2 | IPR001180 | |
| Domain | Quinoprotein_ADH-like_supfam | 3.30e-03 | 53 | 105 | 3 | IPR011047 | |
| Domain | SUSHI | 3.86e-03 | 56 | 105 | 3 | PS50923 | |
| Domain | FN3 | 3.93e-03 | 185 | 105 | 5 | SM00060 | |
| Domain | Ser/Thr_kinase_AS | 4.04e-03 | 357 | 105 | 7 | IPR008271 | |
| Domain | Sushi_SCR_CCP_dom | 4.05e-03 | 57 | 105 | 3 | IPR000436 | |
| Domain | S_TKc | 4.16e-03 | 359 | 105 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 4.35e-03 | 362 | 105 | 7 | PS00108 | |
| Domain | Ig_I-set | 4.39e-03 | 190 | 105 | 5 | IPR013098 | |
| Domain | I-set | 4.39e-03 | 190 | 105 | 5 | PF07679 | |
| Domain | FN3 | 5.34e-03 | 199 | 105 | 5 | PS50853 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TPP2 SMARCA5 PDHB POLD1 CAPN1 PSMC2 HNRNPD STXBP1 SEC24C PRIM2 INTS11 SMARCA1 WDR1 EIF2A FHL3 | 4.00e-09 | 704 | 106 | 15 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB SMARCA5 PDHB MAP4K3 POLD1 CAPN1 PSMC2 EPB41L5 HNRNPD SEC24C PABPN1 MAP4K5 RPTOR PRIM2 INTS11 SMARCA1 CSTA WDR1 EIF2A | 2.56e-08 | 1353 | 106 | 19 | 29467282 |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.75e-08 | 3 | 106 | 3 | 31985401 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.75e-08 | 3 | 106 | 3 | 33656439 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 9784606 | ||
| Pubmed | 1.00e-07 | 257 | 106 | 9 | 16335952 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 8524829 | ||
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 10777529 | ||
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 22357843 | ||
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 19273906 | ||
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 12376545 | ||
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 29073098 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 37591863 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 28637841 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB PDHB POLD1 PSMC2 EPB41L5 LSR MTMR6 MTMR7 PTPRD PTPRF PTPRS WDR1 EIF2A FHL3 | 1.61e-06 | 974 | 106 | 14 | 28675297 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPP2 FLNB SMARCA5 CARS1 EPB41L5 HNRNPD CRIP2 SEC24C CDK13 EIF2A | 3.09e-06 | 498 | 106 | 10 | 36634849 |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 25624497 | ||
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 7832766 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 5.93e-06 | 12 | 106 | 3 | 9624153 | |
| Pubmed | 8.49e-06 | 332 | 106 | 8 | 37433992 | ||
| Pubmed | RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival. | 9.20e-06 | 2 | 106 | 2 | 26195820 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21357822 | ||
| Pubmed | Protein inhibitors form complexes with procathepsin L and augment cleavage of the propeptide. | 9.20e-06 | 2 | 106 | 2 | 12921779 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7665159 | ||
| Pubmed | Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice. | 9.20e-06 | 2 | 106 | 2 | 22869620 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18843291 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23678000 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24743769 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9566880 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27621312 | ||
| Pubmed | 1.38e-05 | 591 | 106 | 10 | 15231748 | ||
| Pubmed | MAP4K3 CAPN1 CARS1 DNASE2B MTMR6 MTMR7 ACSM3 CDK13 ADAM2 ATP6V0A2 CDK3 | 1.48e-05 | 730 | 106 | 11 | 34857952 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.81e-05 | 17 | 106 | 3 | 19727691 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 2.12e-05 | 377 | 106 | 8 | 38117590 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CHL1 FLNB CAPN1 XPNPEP1 ITFG1 PALS1 PTPRD PIGR PTPRS HPR C5 CTSL ENPEP | 2.33e-05 | 1070 | 106 | 13 | 23533145 |
| Pubmed | 2.35e-05 | 277 | 106 | 7 | 30745168 | ||
| Pubmed | Chromatin remodeling enzyme Snf2h regulates embryonic lens differentiation and denucleation. | 2.57e-05 | 19 | 106 | 3 | 27246713 | |
| Pubmed | STON1 EPB41L5 PKHD1L1 RYR2 DNASE2B LSR SEC24C TENM3 CLEC16A SDK1 ATP6V0A2 | 2.61e-05 | 777 | 106 | 11 | 35844135 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20610895 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9585570 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28270653 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17638906 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24398693 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21738833 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12890864 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11359880 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25703008 | ||
| Pubmed | De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1. | 2.76e-05 | 3 | 106 | 2 | 22659130 | |
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 2.76e-05 | 3 | 106 | 2 | 25394468 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20016199 | ||
| Pubmed | The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. | 2.76e-05 | 3 | 106 | 2 | 12215447 | |
| Pubmed | NoRC--a novel member of mammalian ISWI-containing chromatin remodeling machines. | 2.76e-05 | 3 | 106 | 2 | 11532953 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPP2 FLNB SMARCA5 PDHB PSMC2 BCOR STXBP1 CDK13 SMARCA1 TUBAL3 | 3.75e-05 | 665 | 106 | 10 | 30457570 |
| Pubmed | 3.96e-05 | 204 | 106 | 6 | 25659154 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 32221306 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 14967925 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 36134579 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 26231120 | ||
| Pubmed | Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. | 5.50e-05 | 4 | 106 | 2 | 21880013 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 20822712 | ||
| Pubmed | 6.70e-05 | 327 | 106 | 7 | 31409639 | ||
| Pubmed | 6.80e-05 | 26 | 106 | 3 | 36178190 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PDHB MAP4K3 EPB41L5 ITFG1 PALS1 ACSM3 TENM3 HEBP1 PRIM2 CEP152 | 7.18e-05 | 719 | 106 | 10 | 35337019 |
| Pubmed | 7.64e-05 | 334 | 106 | 7 | 30425250 | ||
| Pubmed | TPP2 PDHB PSMC2 PTPN22 BCOR MTMR6 MTMR7 PTPRD PTPRF PTPRS PRIM2 INTS11 | 8.68e-05 | 1049 | 106 | 12 | 27880917 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 16783640 | ||
| Pubmed | Functional heterogeneity of POMC neurons relies on mTORC1 signaling. | 9.15e-05 | 5 | 106 | 2 | 34644574 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 25193470 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 12220650 | ||
| Pubmed | TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. | 9.15e-05 | 5 | 106 | 2 | 17804836 | |
| Pubmed | Proteasome inhibition blocks necroptosis by attenuating death complex aggregation. | 9.15e-05 | 5 | 106 | 2 | 29497034 | |
| Pubmed | Chromosome evolution: the junction of mammalian chromosomes in the formation of mouse chromosome 10. | 9.15e-05 | 5 | 106 | 2 | 11042146 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 19741008 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 19578370 | ||
| Pubmed | Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. | 9.15e-05 | 5 | 106 | 2 | 19180477 | |
| Pubmed | FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. | 9.15e-05 | 5 | 106 | 2 | 26972597 | |
| Pubmed | LRP6 acts as a scaffold protein in cardiac gap junction assembly. | 9.15e-05 | 5 | 106 | 2 | 27250245 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 21737329 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 26865630 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 27056679 | ||
| Pubmed | The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. | 1.37e-04 | 6 | 106 | 2 | 10837247 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 31477895 | ||
| Pubmed | WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci. | 1.37e-04 | 6 | 106 | 2 | 11980720 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 38388459 | ||
| Pubmed | Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. | 1.37e-04 | 6 | 106 | 2 | 16738228 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 23540699 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 16737952 | ||
| Pubmed | Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. | 1.37e-04 | 6 | 106 | 2 | 21368763 | |
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 1.37e-04 | 6 | 106 | 2 | 21126580 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 35379807 | ||
| Pubmed | 1.43e-04 | 162 | 106 | 5 | 25826454 | ||
| Pubmed | 1.50e-04 | 638 | 106 | 9 | 33239621 | ||
| Pubmed | 1.77e-04 | 652 | 106 | 9 | 31180492 | ||
| Pubmed | A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. | 1.91e-04 | 7 | 106 | 2 | 17632545 | |
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 25278099 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 20962236 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 20353580 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 1454056 | ||
| Pubmed | De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. | 1.91e-04 | 7 | 106 | 2 | 22179575 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.02e-04 | 53 | 83 | 4 | 532 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.17e-04 | 21 | 83 | 3 | 813 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 2.06e-04 | 5 | 83 | 2 | 655 | |
| GeneFamily | Cyclin dependent kinases | 2.25e-04 | 26 | 83 | 3 | 496 | |
| GeneFamily | Fibronectin type III domain containing | 8.49e-04 | 160 | 83 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.73e-04 | 161 | 83 | 5 | 593 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.10e-03 | 15 | 83 | 2 | 903 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.28e-03 | 57 | 83 | 3 | 1179 | |
| GeneFamily | LIM domain containing | 2.52e-03 | 59 | 83 | 3 | 1218 | |
| GeneFamily | Aminopeptidases|CD molecules | 2.71e-03 | 17 | 83 | 2 | 104 | |
| GeneFamily | Phosphoinositide phosphatases | 9.45e-03 | 32 | 83 | 2 | 1079 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_5_UP | 1.38e-05 | 12 | 106 | 3 | M2172 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 1.45e-05 | 76 | 106 | 5 | M11825 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-07 | 187 | 106 | 7 | 82bbc107f58c623f3b90430c90c562624a12abef | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.69e-07 | 197 | 106 | 7 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-07 | 198 | 106 | 7 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-07 | 198 | 106 | 7 | 3cc9e671f596ef0829684018e4257571fefb6267 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.85e-07 | 198 | 106 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Goblet_3|World / shred by cell class for nasal brushing | 5.01e-07 | 199 | 106 | 7 | 4229a17a3a6d8855655acc0a1c8704166f8e74c0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.01e-07 | 199 | 106 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 200 | 106 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-06 | 165 | 106 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-06 | 175 | 106 | 6 | dc7721794162dee96944f4b4b87b5681bb02ea8f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.41e-06 | 185 | 106 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-06 | 188 | 106 | 6 | fcf1bebef7aa81b4a11c1f9e4319339c290ecd22 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-06 | 188 | 106 | 6 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-06 | 188 | 106 | 6 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 189 | 106 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-06 | 190 | 106 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.49e-06 | 191 | 106 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.49e-06 | 191 | 106 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.49e-06 | 191 | 106 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-06 | 192 | 106 | 6 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-06 | 192 | 106 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-06 | 192 | 106 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-06 | 193 | 106 | 6 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.89e-06 | 193 | 106 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-06 | 194 | 106 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-06 | 196 | 106 | 6 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-06 | 196 | 106 | 6 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-06 | 196 | 106 | 6 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-06 | 196 | 106 | 6 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-06 | 196 | 106 | 6 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-06 | 197 | 106 | 6 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.74e-06 | 197 | 106 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-06 | 197 | 106 | 6 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.97e-06 | 198 | 106 | 6 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.97e-06 | 198 | 106 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.20e-06 | 199 | 106 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.20e-06 | 199 | 106 | 6 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 8c9ec5f05b79cf5ae1bf7aade603c171fb0226a9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.44e-06 | 200 | 106 | 6 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.44e-06 | 200 | 106 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.44e-06 | 200 | 106 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.44e-06 | 200 | 106 | 6 | 694ebc8cc14f80b6f2f4acec4ce7452d8b816af8 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | ea1325ca6039c6d2318b1ceb9d396399bb21b670 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-05 | 134 | 106 | 5 | bffd6ce8998368d4f486b64c220eab3a44ba147b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-05 | 161 | 106 | 5 | 9cfbbcd38ec2e75376bbc26001964b6991ad0e21 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 165 | 106 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 165 | 106 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.26e-05 | 169 | 106 | 5 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.41e-05 | 170 | 106 | 5 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 171 | 106 | 5 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 171 | 106 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.71e-05 | 172 | 106 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-05 | 173 | 106 | 5 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.87e-05 | 173 | 106 | 5 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 173 | 106 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-05 | 173 | 106 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-05 | 174 | 106 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 176 | 106 | 5 | 56e19240f4a7b617a986e3c0854b757394e78251 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 176 | 106 | 5 | c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 176 | 106 | 5 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.72e-05 | 178 | 106 | 5 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 178 | 106 | 5 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-05 | 179 | 106 | 5 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-05 | 179 | 106 | 5 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 179 | 106 | 5 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-05 | 179 | 106 | 5 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.90e-05 | 179 | 106 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.90e-05 | 179 | 106 | 5 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 6.90e-05 | 179 | 106 | 5 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 179 | 106 | 5 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.09e-05 | 180 | 106 | 5 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 180 | 106 | 5 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 180 | 106 | 5 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.09e-05 | 180 | 106 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.47e-05 | 182 | 106 | 5 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-05 | 183 | 106 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-05 | 183 | 106 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-05 | 183 | 106 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.66e-05 | 183 | 106 | 5 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.05e-06 | 190 | 106 | 8 | 3331_DN | |
| Drug | 3-methyladenine | 3.14e-06 | 134 | 106 | 7 | CID000001673 | |
| Disease | azoospermia (implicated_via_orthology) | 2.40e-06 | 27 | 104 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | bitter alcoholic beverage consumption measurement | 1.11e-04 | 133 | 104 | 5 | EFO_0010092 | |
| Disease | Addison's disease (is_implicated_in) | 1.22e-04 | 5 | 104 | 2 | DOID:13774 (is_implicated_in) | |
| Disease | uridine measurement | 1.96e-04 | 32 | 104 | 3 | EFO_0010546 | |
| Disease | Neurodevelopmental delay | 2.55e-04 | 7 | 104 | 2 | C4022738 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0801657 | |
| Disease | pit and fissure surface dental caries | 2.56e-04 | 35 | 104 | 3 | EFO_0006338 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 3.28e-04 | 38 | 104 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | ulcerative colitis (is_marker_for) | 3.82e-04 | 40 | 104 | 3 | DOID:8577 (is_marker_for) | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 4.36e-04 | 9 | 104 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | response to carboplatin, response to antineoplastic agent | 5.44e-04 | 10 | 104 | 2 | GO_0097327, GO_0097328 | |
| Disease | protein intake measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0010810 | |
| Disease | disease progression measurement, Crohn's disease | 6.16e-04 | 47 | 104 | 3 | EFO_0000384, EFO_0008336 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.49e-04 | 195 | 104 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | fibroblast growth factor 21 measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0010783 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 7.27e-04 | 200 | 104 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | alcohol consumption measurement, alcohol drinking | 7.94e-04 | 12 | 104 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | Colorectal Carcinoma | 8.55e-04 | 702 | 104 | 9 | C0009402 | |
| Disease | serum selenium measurement | 8.77e-04 | 53 | 104 | 3 | EFO_0005266 | |
| Disease | triacylglycerol 46:2 measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0010402 | |
| Disease | triacylglycerol 52:1 measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0010413 | |
| Disease | eating disorder, bipolar disorder | 1.09e-03 | 14 | 104 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.20e-03 | 59 | 104 | 3 | EFO_0009658, GO_0009410 | |
| Disease | insulin resistance | 1.20e-03 | 59 | 104 | 3 | EFO_0002614 | |
| Disease | hepcidin:transferrin saturation ratio | 1.25e-03 | 15 | 104 | 2 | EFO_0007902 | |
| Disease | YKL40 measurement | 1.25e-03 | 15 | 104 | 2 | EFO_0004869 | |
| Disease | response to triptolide, cytotoxicity measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.43e-03 | 16 | 104 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | partial epilepsy | 1.62e-03 | 17 | 104 | 2 | EFO_0004263 | |
| Disease | theta wave measurement | 1.62e-03 | 17 | 104 | 2 | EFO_0006873 | |
| Disease | triacylglycerol 48:1 measurement | 1.62e-03 | 17 | 104 | 2 | EFO_0010404 | |
| Disease | Liver Cirrhosis, Experimental | 1.68e-03 | 774 | 104 | 9 | C0023893 | |
| Disease | Child Behaviour Checklist assessment | 1.81e-03 | 18 | 104 | 2 | EFO_0005661 | |
| Disease | glucuronate measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0010486 | |
| Disease | sarcopenia | 2.24e-03 | 20 | 104 | 2 | EFO_1000653 | |
| Disease | exercise test | 2.24e-03 | 20 | 104 | 2 | EFO_0004328 | |
| Disease | triacylglycerol 46:1 measurement | 2.24e-03 | 20 | 104 | 2 | EFO_0010401 | |
| Disease | prothrombin time measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0008390 | |
| Disease | Attention Deficit Disorder | 2.71e-03 | 22 | 104 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 2.71e-03 | 22 | 104 | 2 | C1321905 | |
| Disease | triacylglycerol 48:2 measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0010405 | |
| Disease | triacylglycerol 48:3 measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0010406 | |
| Disease | amino acid measurement | 2.78e-03 | 678 | 104 | 8 | EFO_0005134 | |
| Disease | Immunologic Deficiency Syndromes | 2.97e-03 | 23 | 104 | 2 | C0021051 | |
| Disease | Colorectal Neoplasms | 3.04e-03 | 277 | 104 | 5 | C0009404 | |
| Disease | Hodgkins lymphoma | 3.08e-03 | 82 | 104 | 3 | EFO_0000183 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 3.23e-03 | 24 | 104 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 3.23e-03 | 24 | 104 | 2 | EFO_0006897 | |
| Disease | Attention deficit hyperactivity disorder | 3.23e-03 | 24 | 104 | 2 | C1263846 | |
| Disease | nicotine dependence symptom count | 3.43e-03 | 285 | 104 | 5 | EFO_0009262 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDVNNYKGRYSEGDT | 611 | Q15361 | |
| VNGYNEIQSLYAGEK | 86 | O94986 | |
| ISGDGFSYRDTVVYQ | 2691 | Q96PZ7 | |
| RTGYSLVQENGQRKY | 26 | Q9NQ94 | |
| YNGAIIVSGDQKDYR | 866 | Q8WWZ4 | |
| ETNDNTAQLGGKYRY | 91 | P59827 | |
| YREKSNYVGATFQGK | 271 | Q99965 | |
| ASRNNNEVYGKESYG | 991 | Q86SQ4 | |
| QKVAYGGTGDAATRY | 301 | P30838 | |
| SYNGLYGVAVFSQKD | 666 | Q9UK96 | |
| QDYIRGYVLQDASGK | 136 | Q01954 | |
| YHYQSEGTERQKGQS | 3956 | P20930 | |
| GHAYSVTGAKQVNYR | 271 | P07384 | |
| GEYYVENADGKVTVR | 1381 | Q6W2J9 | |
| YKQSVQGAGTSYRNV | 171 | O15519 | |
| KREGGIDYQAGDTYV | 1316 | Q14004 | |
| SYEITSQNVKDGGRY | 406 | P49758 | |
| NISQKGDVYSYGIIA | 656 | P25092 | |
| DSSYINANFIKGVYG | 81 | Q9Y2R2 | |
| SGRKEANYYGSLTQA | 91 | Q9NPH2 | |
| AGQTYVDAGYEVDKI | 186 | Q13231 | |
| LGEEVAQYDGAYKVS | 56 | P11177 | |
| TYGDVYKARNVNTGE | 26 | Q8IVH8 | |
| QTKDGENYATVVGYS | 426 | O00533 | |
| VRYTEDYEQQRGKGS | 226 | Q86VF7 | |
| IKVGSESVVYTGDYN | 166 | Q5TA45 | |
| AGKGYENEDNYSNIR | 251 | Q9Y217 | |
| RAAGKGYENEDNYSN | 251 | Q9Y216 | |
| SKNYAEVGRVGYVSG | 211 | P00739 | |
| KGAYGVVRLAYNESE | 136 | Q8N5S9 | |
| ALQRSTQYDGYAKTD | 671 | Q5U5R9 | |
| SIQNNKDGTYAVTYV | 1181 | O75369 | |
| GAISRETQNGYYVKS | 346 | O60462 | |
| FQSEKETGDRNYAIG | 311 | Q9UI32 | |
| VGFYRTTYTENGQVK | 201 | Q07075 | |
| QESYTFYVKAEDGGR | 636 | Q9BZA7 | |
| DGTYYGDQKQETISV | 1106 | Q13219 | |
| IDGYRQQKAYIATQG | 1741 | Q13332 | |
| AQDSKAYTSILYGNG | 401 | P09923 | |
| RVYESIGQYGGETVK | 241 | Q8N3R9 | |
| VENLGVSYVKGTEQY | 56 | P49643 | |
| ARSIYVGNVDYGATA | 171 | Q86U42 | |
| GEGTYGVVYKAKNRE | 11 | Q00526 | |
| AYYQVGQTGKEGTEN | 1771 | Q9Y2I7 | |
| KEYRGQTPAQAETNY | 206 | Q9HCM4 | |
| NESLYGRKYIQTDSG | 11 | Q13643 | |
| RQNKESGETGLEYLY | 51 | Q8WZ79 | |
| EGSYATVYKGISRIN | 111 | Q96Q40 | |
| TAVGGESIYYDEQSK | 36 | P36383 | |
| GEQIQLKGTVYNYRT | 836 | P01031 | |
| LYVGSNDIQYEDIKG | 21 | P21554 | |
| QVVAGTNYYIKVRAG | 46 | P01040 | |
| QTYAYEGQRSEAGSI | 736 | Q13634 | |
| DGIVTVANAKGLQYY | 161 | Q86Z14 | |
| DNLVYVYTVDQGGRK | 481 | O95834 | |
| DGKYIQVSTGAYKRQ | 1826 | Q6ZMW3 | |
| TDVDKTGASYYGEQT | 241 | Q9BY44 | |
| KGVNTGAVGSYIYDR | 186 | P52943 | |
| LAQDTGTGTAYIEYK | 501 | Q14689 | |
| TGGSVYKYASFQVEN | 716 | P53992 | |
| AGAYYVQAVNEKNGE | 256 | Q7Z5N4 | |
| SRYAAIYNGGVEAVS | 326 | O60779 | |
| YYSGKDVIDEQGQRN | 3891 | Q92736 | |
| VENGYSTSAKVVYGD | 741 | P28340 | |
| VATKQGNAVTLGDYY | 176 | Q86X29 | |
| VGSGTYGDVYKARNV | 26 | Q9Y4K4 | |
| IDGYRKQNAYIATQG | 1411 | P10586 | |
| IDGYRKQNAYIATQG | 1416 | P23468 | |
| DYSNQQSGYGKVSRR | 331 | Q14103 | |
| YGQSTYSRQIKQVED | 36 | P35998 | |
| FVQKIVDNGYGYVSN | 251 | P49589 | |
| RIQYGTSKGKNYTEE | 951 | P28370 | |
| YANGSRTETQVGIYI | 91 | O95084 | |
| TGYSADVGNKTTYRV | 141 | Q969X2 | |
| YQYLGLGETVQEDKT | 1146 | Q5VXU9 | |
| VGGYESFTEKYVNAT | 226 | Q9NY91 | |
| YVSEFEGLQNKINYG | 271 | Q96LZ7 | |
| SGKEDAANNYARGRY | 101 | A6NHL2 | |
| TASADGQIYIYDGKT | 206 | O75083 | |
| YENFQNTEGKGTAYS | 426 | Q13546 | |
| NDVYKYETSGIGEAR | 261 | P61764 | |
| NSSGELINNIKYYDG | 1281 | Q8N122 | |
| VGYGFESTESDNNKY | 281 | P07711 | |
| NKTGLDIYEGYGQTE | 366 | Q53FZ2 | |
| LYVYSLENQDKGGER | 291 | Q2KHT3 | |
| DVVGAATAGQTYYRS | 881 | Q14028 | |
| IDLKGVEGYGNDQTY | 671 | Q7KZ85 | |
| VYLIDSGAQYKDGTT | 411 | Q9NQW7 | |
| SKEAAYGTSQVQYDV | 61 | Q8N443 | |
| QVTVGSAKYESAYQA | 616 | Q9Y6Q2 | |
| YVEINGEKYCGERSQ | 401 | Q9Y5Y6 | |
| NYKEAQEYGSFGTAE | 226 | P29144 | |
| DGVGVQYKDYIQSER | 46 | P53804 | |
| AYNQKVYGLSEAVVS | 1066 | Q9P273 | |
| SANGITVSADQKYVY | 221 | Q15166 | |
| KYNVGAAESSYREVV | 3086 | Q86WI1 | |
| EGYVSSKYAGRANLT | 71 | P01833 | |
| EITSNSRYEVYTQGG | 91 | Q92889 | |
| YTTVDANGYLKNGSA | 471 | Q8TB96 | |
| RISYGTNKGKNYTEE | 936 | O60264 | |
| VDYLENYGRKGSASQ | 196 | O75604 | |
| SKTSGLYTGQEYVQR | 636 | Q9Y487 | |
| KNQYVVSIGNSVGYE | 1231 | Q5THJ4 | |
| GGYAKEADYVAQATR | 136 | Q9NRV9 | |
| VDVIVAASNYYKGEN | 396 | Q8IZF0 | |
| DTQAKYQSYFSRGGA | 671 | Q5VVJ2 |